Adam Bedeir (KEYS ‘23) and Jishnu Nayak (KEYS ‘24) have earned one of Arizona’s most prestigious academic honors for high school students and will be attending the University of Arizona in fall 2025.

BIO5 members Dongkyun Kang and Clara Curiel-Lewandrowski are part of a team that hope to image nerve endings and create objective, quantitative biomarkers for chemotherapy-induced peripheral neuropathy, or CIPN, a common and painful side effect of chemotherapy drugs.

Branch Therapeutics, a University of Arizona startup co-founded by BIO5 members Christopher Hulme and Curtis Thorne, has received $4 million in seed funding to advance its development of targeted therapies for cancer and other diseases.